[{"uuid": "6a7ed206-1a06-31a1-901a-c79b6f25ee70", "title": "BofA Adjusts Price Target on BioMarin Pharmaceutical to $99 From $100", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/bofa-adjusts-price-target-biomarin-152636103.html", "providerPublishTime": 1738596396, "type": "STORY", "relatedTickers": ["BMRN"]}, {"uuid": "45bccb20-268d-3075-a01b-a9521d2dfc3a", "title": "BMY Gets Positive CHMP Opinion for Opdivo, Yervoy Combo and Breyanzi", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/bmy-gets-positive-chmp-opinion-183400618.html", "providerPublishTime": 1738607640, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/SlGE5JR4xp73Vb5zTu29cQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/iAjYTqhtpV3hPzryhmSe_g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CELG-RT"]}, {"uuid": "7ae6ed39-40ab-38b2-9472-fbd0145412e6", "title": "Will Non-COVID Drugs Drive PFE's Top Line in Q4 Earnings?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/non-covid-drugs-drive-pfes-155300754.html", "providerPublishTime": 1738597980, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/OqpBwYnlazUrZRs4ONCSFw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/o6eSXhh4drUv4ud46ya1fg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["PFE", "ALNY", "BMRN"]}, {"uuid": "03730b0f-1b37-3159-ad6b-ad4a125314c8", "title": "Novartis Posts Q4 Earnings and Sales Beat, Shares Gain", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/novartis-posts-q4-earnings-sales-182000131.html", "providerPublishTime": 1738347600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/1GILAZNg_sZU4tvhUip3sw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f166d65586ad9d3236a947b8d942f4c9", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/yDFbSqgx8Di1WnwdhMZtig--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/f166d65586ad9d3236a947b8d942f4c9", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["NVS"]}, {"uuid": "4914726d-3902-3b70-823c-e739fe9b7948", "title": "Compass Therapeutics Stock Skyrockets 108% in a Month: Here's Why", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/compass-therapeutics-stock-skyrockets-108-162000718.html", "providerPublishTime": 1738340400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/cYhdSHZ3kDYVQNhcMTsM_w--~B/aD0zOTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890", "width": 620, "height": 393, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/W5ve9LofNukkX0a38W9plQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "75dc85f7-7a55-3ab4-89cc-cf80c9af21c3", "title": "Axsome Gets FDA Nod for New Migraine Drug Symbravo, Stock Rises", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/axsome-gets-fda-nod-migraine-155100511.html", "providerPublishTime": 1738338660, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/KEj1lCkxRqndrrMrF3m.HA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/L9oXp_PBujUXs0r0RIkKrg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AXSM"]}, {"uuid": "2fec5bb4-679f-3136-a6b2-5db18f3d2a8c", "title": "VRTX Gets FDA Nod for Non-Opioid Pain Drug Journavx, Shares Up", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/vrtx-gets-fda-nod-non-155600022.html", "providerPublishTime": 1738338960, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/KEj1lCkxRqndrrMrF3m.HA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/L9oXp_PBujUXs0r0RIkKrg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["VRTX"]}, {"uuid": "fc2b055c-6da9-3c13-9fb7-491bc3c9cf47", "title": "CMRX Stock Skyrockets in 3 Months: Here's What You Should Know", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/cmrx-stock-skyrockets-3-months-154300643.html", "providerPublishTime": 1738338180, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/wYQLwM.yHAc_hHptSu_lhQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/701e76528de32ecfd8ed3df2f647e9a8", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/eA5p1GotBcGPlbcSkQjmLA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/701e76528de32ecfd8ed3df2f647e9a8", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CMRX"]}, {"uuid": "7f70f8a1-2ced-35df-8bb6-b96b6f198d92", "title": "IRWD Begins Apraglutide NDA Submission, Announces Job Cuts, Stock Falls", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/irwd-begins-apraglutide-nda-submission-164800782.html", "providerPublishTime": 1738255680, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.WQmSb1MJO1_eLnmBVS1zA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/pa5q6Axi5bBp9pCuwXBcUg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["IRWD", "ABBV"]}, {"uuid": "245ece04-31c6-3373-bfd7-c64d16e42a7e", "title": "Why This 1 Value Stock Could Be a Great Addition to Your Portfolio", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/why-1-value-stock-could-144011852.html", "providerPublishTime": 1738248011, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/hYDVEF34jJNULlluFRTwjg--~B/aD05MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/39dfb058875b6e691de9136bc97a47b4", "width": 900, "height": 900, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/SurBRNrCPD6U_NI2v5UP3A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/39dfb058875b6e691de9136bc97a47b4", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BMRN"]}, {"uuid": "27d142b2-8f06-3f9b-8fd4-deb40dc094a6", "title": "BMRN vs. CSLLY: Which Stock Should Value Investors Buy Now?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/bmrn-vs-cslly-stock-value-164014669.html", "providerPublishTime": 1737996014, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ksLAzii1aL14haHFbPC1Rg--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/bdc2850a48a0f40806db817a9e24f36f", "width": 900, "height": 601, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/sz.PXkOG_KtvLQskImJYTA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/bdc2850a48a0f40806db817a9e24f36f", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CSL.AX", "BMRN"]}, {"uuid": "335d0b5f-cf32-3521-aa0b-e69189d33f91", "title": "FDA Clears Allogene's IND for CAR T Therapy in Autoimmune Diseases", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/fda-clears-allogenes-ind-car-163400440.html", "providerPublishTime": 1738168440, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/_9OKqED6rOANF8VtUei37A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/QSgbLgHaS28STBWt5rEywQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALLO"]}]